Sinovac director reports 18.5M-share indirect stake

SINOVAC BIOTECH LTD director Li Jiaqiang filed an initial ownership report showing indirect control over 18,515,315 common shares of the company.

Rhea-AI Filing Summary

SINOVAC BIOTECH LTD director Li Jiaqiang filed an initial ownership report showing indirect control over 18,515,315 common shares of the company. These common shares, with par value $0.001 per share, are held through investment entities and related parties rather than directly.

The position consists of 6,812,855 common shares held by 1Globe Capital LLC, 6,000,000 common shares held by CDH Utopia Limited, and 5,702,460 common shares held by relatives or related parties. The filing notes that Li may be deemed the ultimate beneficial owner but disclaims beneficial ownership except to the extent of his pecuniary interest.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Li Jiaqiang

Role Director

Type	Security	Shares	Price	Value
holding	Common shares, par value $0.001 per share	--	--	--

Holdings After Transaction: Common shares, par value $0.001 per share — 18,515,315 shares (Indirect, By 1Globe Capital LLC, CDH Utopia Limited and the others)

Footnotes (3)

1. F1. Represented (i) 6,812,855 Common shares, par value $0.001 per share, of the Issuer (the "Common Shares") held directly by 1Globe Capital LLC; (ii) 6,000,000 Common Shares held by CDH Utopia Limited (the "Subject Shares"), (x) over 70% of which 1Globe Biomedical (Hong Kong) Company Limited posseses the voting rights and (y) over all the which 1Globe Biomedical (Hong Kong) Company Limited posseses the voting rights over certain financial upside; and (iii) 5,702,460 Common Shares held by relatives or related parties of the Reporting Person.
2. F2. 1Globe Biomedical (Hong Kong) Company Limited is the sole member of 1Globe Capital LLC and may be deemed to beneficially own the Common Shares held by 1Globe Capital LLC. 1Globe Biomedical (Hong Kong) Company Limited may be deemed to beneficially own the Subject Shares held by CDH Utopia Limited. The Reporting Person is the Chairman of each of 1Globe Capital LLC and 1Globe Biomedical (Hong Kong) Company Limited. The Reporting Person may be deemed the ultimate beneficial owner of the Common Shares held by 1Globe Capital LLC, 1Globe Biomedical (Hong Kong) Company Limited and his relatives.
3. F3. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

Key Figures

Indirect common shares held: 18,515,315 common shares Shares held by 1Globe Capital LLC: 6,812,855 common shares Shares held by CDH Utopia Limited: 6,000,000 common shares +2 more

5 metrics

Indirect common shares held 18,515,315 common shares Total common shares following the reported holding

Shares held by 1Globe Capital LLC 6,812,855 common shares Common shares of SINOVAC BIOTECH LTD held directly by 1Globe Capital LLC

Shares held by CDH Utopia Limited 6,000,000 common shares Subject Shares of SINOVAC BIOTECH LTD held by CDH Utopia Limited

Shares held by relatives/related parties 5,702,460 common shares Common shares attributed to relatives or related parties of the reporting person

Par value per common share $0.001 per share Par value of SINOVAC BIOTECH LTD common shares

Key Terms

Common shares, indirect, beneficially own, pecuniary interest, +1 more

5 terms

Common shares financial

"Common shares, par value $0.001 per share, of the Issuer (the "Common Shares")"

Common shares are the basic units of ownership in a company that give holders a claim on profits and a right to vote on key matters, like electing the board. Think of them as membership cards in a club: they let you share in successes and losses, but in a bankruptcy or liquidation they are paid after creditors and preferred shareholders, so their value can swing more and matters for assessing risk and potential return.

indirect financial

"total_shares_following_transaction ... ownership_type": "indirect""

beneficially own financial

"may be deemed to beneficially own the Common Shares held by 1Globe Capital LLC"

Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.

pecuniary interest financial

"disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein"

Section 16 regulatory

"shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16"

Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider position did Li Jiaqiang report in SINOVAC BIOTECH LTD (SVA)?

Li Jiaqiang reported indirect control over 18,515,315 common shares of SINOVAC BIOTECH LTD. These shares are held through 1Globe Capital LLC, CDH Utopia Limited, and relatives or related parties, rather than in his own name, and reflect his reported indirect equity exposure.

How are the 18,515,315 SINOVAC common shares held that are linked to Li Jiaqiang?

The 18,515,315 common shares are held in three blocks: 6,812,855 shares by 1Globe Capital LLC, 6,000,000 shares by CDH Utopia Limited, and 5,702,460 shares by relatives or related parties. All are common shares with a par value of $0.001 per share.

What role do 1Globe Capital LLC and CDH Utopia Limited play in Li Jiaqiang’s SINOVAC holdings?

1Globe Capital LLC directly holds 6,812,855 common shares, while CDH Utopia Limited holds 6,000,000 common shares. 1Globe Biomedical (Hong Kong) Company Limited is the sole member of 1Globe Capital LLC and may be deemed to beneficially own both these blocks of shares.

Does Li Jiaqiang claim full beneficial ownership of his reported SINOVAC shares?

Li Jiaqiang expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest. The filing states that including these shares should not be seen as an admission of beneficial ownership for Section 16 or any other purpose.

How are relatives and related parties reflected in Li Jiaqiang’s SINOVAC ownership disclosure?

The filing attributes 5,702,460 common shares to relatives or related parties of Li Jiaqiang. It notes that he may be deemed the ultimate beneficial owner of shares held by these relatives, but he disclaims beneficial ownership beyond his actual pecuniary interest.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/17/2026 - 06:10 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Li Jiaqiang

(Last) (First) (Middle)

ONE INTERNATIONAL PL

44TH FLOOR

(Street)

BOSTON MASSACHUSETTS 02110

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/17/2026

3. Issuer Name and Ticker or Trading Symbol
SINOVAC BIOTECH LTD [ SVA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common shares, par value $0.001 per share	18,515,315	I	By 1Globe Capital LLC, CDH Utopia Limited and the others(1)(2)(3)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represented (i) 6,812,855 Common shares, par value $0.001 per share, of the Issuer (the "Common Shares") held directly by 1Globe Capital LLC; (ii) 6,000,000 Common Shares held by CDH Utopia Limited (the "Subject Shares"), (x) over 70% of which 1Globe Biomedical (Hong Kong) Company Limited posseses the voting rights and (y) over all the which 1Globe Biomedical (Hong Kong) Company Limited posseses the voting rights over certain financial upside; and (iii) 5,702,460 Common Shares held by relatives or related parties of the Reporting Person.

2. 1Globe Biomedical (Hong Kong) Company Limited is the sole member of 1Globe Capital LLC and may be deemed to beneficially own the Common Shares held by 1Globe Capital LLC. 1Globe Biomedical (Hong Kong) Company Limited may be deemed to beneficially own the Subject Shares held by CDH Utopia Limited. The Reporting Person is the Chairman of each of 1Globe Capital LLC and 1Globe Biomedical (Hong Kong) Company Limited. The Reporting Person may be deemed the ultimate beneficial owner of the Common Shares held by 1Globe Capital LLC, 1Globe Biomedical (Hong Kong) Company Limited and his relatives.

3. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

	/s/ Jiaqiang Li	04/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)